Navigation Links
Nobles Medical Technologies II's NobleStitch EL begins Sales in Europe
Date:5/28/2013

Fountain Valley, California (PRWEB) May 28, 2013

Dr Michael Mullen, a Consultant Cardiologist at University College Hospital London, UK and a member of the NMT2 Clinical Advisory Board performed the procedures using the latest generation of the NobleStitch.

The patients all received the procedure to suture their PFO closed without the use of a metallic implant or the need for long term anticoagulation. “The clinical benefit of PFO closure without leaving any device behind are significant, I am excited to watch the long term results of patients who have this technology versus a metal implant left in the hearts.” Said Dr. Mullen. Also present at the cases for training was Prof. Dr. Anthony Nobles, CEO of NMT2 who commented “The cases were very smooth and Dr. Mullen is such an expert that very little additional training was required, we look forward to carrying on this same success with all of our new customers”.

About Patent Foramen Ovale (PFO)
A PFO is a tunnel that exists between the left and right atrium of the heart. The tunnel, which is part of the normal fetal anatomy, should close shortly after birth. In 27% of the population the tunnel never closes. This tunnel can then allow clots and other chemicals to pass from the right to the left side of the heart freely bypassing the filter of the lungs. These clots and chemicals can cause strokes and other conditions such as severe migraines.

About the NobleStitch EL System
Nobles Medical Technologies II's NobleStitch EL is a catheter based system that allows a physician to place a suture in the PFO tunnel in the heart through a percutaneous puncture in the leg, in many cases under a local anesthetic in a catheter lab rather than an operating room. This eliminates the need for open-heart surgery or placement of a large metallic implant in the heart. The NobleStitch is not a “device” or mechanical implant it only places a simple polypropylene suture in the heart. By closing the hole or PFO, the therapy will reduce or eliminate the shunting from the right to the left side of the heart allowing the lungs to filter the clots and other chemicals from making it to the brain, potentially halting strokes and severe migraines and enabling patients to live a higher-quality life.

About Nobles Medical Technologies II
Nobles Medical Technologies II is a global structural heart company devoted to improving life through the development of its products and technologies. Nobles Medical Technologies II is focused on suture based solutions for the septum.

Visit Nobles Medical Technologies II http://www.noblesmedicaltechnology.com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10774928.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kids Poisoned by Medical Marijuana, Study Finds
2. The analysis of medical images is improved to facilitate the study of psychotic disorders
3. DiscountMedicalSupplies.com Reaches Out to More People in Need of Low-Price Medical Supplies Through Valpak
4. Just Home Medical Debuts Updated Selection of Overbed Tables
5. Cherry Creek Medical Weight Loss Has Reached Their Goal
6. CEO of Sirtex Medical Gilman Wong Selected for Inclusion in The CEO Magazine
7. California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014
8. Many Medical Students Have Anti-Fat Bias, Study Finds
9. General Data Acquires Triangle Biomedical Sciences
10. Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld
11. New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, ... the first in a new class of photodynamic cosmetics (PDC). , Allumera® is ... visibly reduce outward signs of aging, and minimize the appearance of pores – ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment can hurt the ... overall productivity and performance in the workplace. The goal of Clearview Resolution Services has ... weeks of April, Clearview Resolution Services will be shutting down the office early on ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new patients ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients can ... more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... , April 19, 2017 Global Prostate ... report on the prostate cancer therapeutics market analyzes ... market. Increasing prevalence of prostate cancer, launch of ... the development of new drugs & therapeutic biological ... drug due to lesser side effects are some ...
Breaking Medicine Technology: